Annual EBITDA
-$51.57 M
-$40.35 M-359.69%
March 31, 2024
Summary
- As of February 8, 2025, LSB annual EBITDA is -$51.57 million, with the most recent change of -$40.35 million (-359.69%) on March 31, 2024.
- During the last 3 years, LSB annual EBITDA has fallen by -$34.33 million (-199.18%).
- LSB annual EBITDA is now -392.96% below its all-time high of -$10.46 million, reached on March 1, 2022.
Performance
LSB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
N/A
September 1, 2024
Summary
- LSB quarterly EBITDA is not available.
Performance
LSB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
N/A
September 1, 2024
Summary
- LSB TTM EBITDA is not available.
Performance
LSB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LSB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -359.7% | - | - |
| 3 y3 years | -199.2% | - | - |
| 5 y5 years | -199.2% | - | - |
LSB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -393.0% | at low | ||||
| 5 y | 5-year | -393.0% | at low | ||||
| alltime | all time | -393.0% | at low |
LakeShore Biopharma Co Ltd EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$51.57 M(+359.7%) | - | - |
| Sep 2023 | - | -$13.86 M(+56.4%) | -$22.72 M(+250.2%) |
| Jun 2023 | - | -$8.86 M(-473.3%) | -$6.49 M(-1149.3%) |
| Mar 2023 | -$11.22 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $2.37 M(-235.2%) | $618.20 K(-135.2%) |
| Jun 2022 | - | -$1.76 M | -$1.76 M |
| Mar 2022 | -$10.46 M(-39.3%) | - | - |
| Mar 2021 | -$17.24 M | - | - |
FAQ
- What is LakeShore Biopharma Co Ltd annual EBITDA?
- What is the all time high annual EBITDA for LakeShore Biopharma Co Ltd?
- What is LakeShore Biopharma Co Ltd annual EBITDA year-on-year change?
- What is the all time high quarterly EBITDA for LakeShore Biopharma Co Ltd?
- What is the all time high TTM EBITDA for LakeShore Biopharma Co Ltd?
What is LakeShore Biopharma Co Ltd annual EBITDA?
The current annual EBITDA of LSB is -$51.57 M
What is the all time high annual EBITDA for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high annual EBITDA is -$10.46 M
What is LakeShore Biopharma Co Ltd annual EBITDA year-on-year change?
Over the past year, LSB annual EBITDA has changed by -$40.35 M (-359.69%)
What is the all time high quarterly EBITDA for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high quarterly EBITDA is $2.37 M
What is the all time high TTM EBITDA for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high TTM EBITDA is $618.20 K